<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7291249\results\search\disease\results.xml">
  <result pre=": Review Host Protective Immune Responses against Influenza A Virus" exact="Infection" post="https://orcid.org/0000-0001-6501-6810JungHi Eun1*https://orcid.org/0000-0002-3977-1510LeeHeung Kyu12*[1], [2], *Correspondence: euphoric@kaist.ac.kr (H.E.J.); heungkyu.lee@kaist.ac.kr (H.K.L.);"/>
  <result pre="Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Influenza viruses cause" exact="infectious" post="respiratory disease characterized by fever, myalgia, and congestion, ranging"/>
  <result pre="Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Influenza viruses cause infectious" exact="respiratory" post="disease characterized by fever, myalgia, and congestion, ranging in"/>
  <result pre="(CC BY) license (http://creativecommons.org/licenses/by/4.0/). Abstract Influenza viruses cause infectious respiratory" exact="disease" post="characterized by fever, myalgia, and congestion, ranging in severity"/>
  <result pre="responses 1. Introduction The influenza virus, or â€˜fluâ€™, causes an" exact="acute" post="respiratory disease that results in moderate to severe symptoms"/>
  <result pre="1. Introduction The influenza virus, or â€˜fluâ€™, causes an acute" exact="respiratory" post="disease that results in moderate to severe symptoms including"/>
  <result pre="Introduction The influenza virus, or â€˜fluâ€™, causes an acute respiratory" exact="disease" post="that results in moderate to severe symptoms including fever,"/>
  <result pre="disease that results in moderate to severe symptoms including fever," exact="runny nose," post="cough, muscle pain, headaches, and sometimes even death. Each"/>
  <result pre="in moderate to severe symptoms including fever, runny nose, cough," exact="muscle" post="pain, headaches, and sometimes even death. Each year, seasonal"/>
  <result pre="Administration (FDA). These drugs target several distinct steps of the" exact="viral" post="replication cycle to inhibit influenza propagation in hosts. Matrix"/>
  <result pre="in hosts. Matrix 2 (M2) inhibitors block the release of" exact="viral" post="ribonucleoproteins (vRNPs) into the cytosol, and neuraminidase (NA) inhibitors"/>
  <result pre="[2,3], targets the influenza polymerase acidic (PA) endonuclease to prevent" exact="viral" post="replication [4]. While these drugs are currently effective, they"/>
  <result pre="describe the virological characteristics of influenza A viruses that facilitate" exact="viral" post="propagation in host cells and the mechanisms by which"/>
  <result pre="Features of Influenza A Virus The influenza virus is a" exact="respiratory" post="pathogen that causes acute febrile disease called influenza or"/>
  <result pre="Virus The influenza virus is a respiratory pathogen that causes" exact="acute" post="febrile disease called influenza or flu. It belongs to"/>
  <result pre="influenza virus is a respiratory pathogen that causes acute febrile" exact="disease" post="called influenza or flu. It belongs to the Orthomyxoviridae"/>
  <result pre="including humans, pigs, and birds. The influenza viruses that cause" exact="disease" post="in humans are classified into three typesâ€&quot;influenza type A,"/>
  <result pre="that cause disease in humans are classified into three typesâ€&quot;influenza" exact="type A," post="B, and Câ€&quot;primarily based on antigenic differences in their"/>
  <result pre="it remains unclear whether influenza D virus (IDV) can cause" exact="disease" post="in humans. While IDV infection in humans has not"/>
  <result pre="D virus (IDV) can cause disease in humans. While IDV" exact="infection" post="in humans has not yet been reported, IDV specific"/>
  <result pre="circulates later in the season, is responsible for 15â€&quot;30% of" exact="total" post="influenza infections [14]. While the disease severity due to"/>
  <result pre="in the season, is responsible for 15â€&quot;30% of total influenza" exact="infections" post="[14]. While the disease severity due to both types"/>
  <result pre="responsible for 15â€&quot;30% of total influenza infections [14]. While the" exact="disease" post="severity due to both types is comparable [15,16,17], IBV"/>
  <result pre="negative-sense RNA that is split into eight segments encoding a" exact="total" post="of 11 viral proteins: HA, NA, M1, M2, NP,"/>
  <result pre="is split into eight segments encoding a total of 11" exact="viral" post="proteins: HA, NA, M1, M2, NP, non-structural protein 1"/>
  <result pre="Each segment forms a vRNP complex that is comprised of" exact="viral" post="RNA and NP, which then combines with the RNA"/>
  <result pre="M1 protein, which exists only on the inside of the" exact="viral" post="envelope, interacts with vRNPs [19]. The viral envelope of"/>
  <result pre="inside of the viral envelope, interacts with vRNPs [19]. The" exact="viral" post="envelope of IAV consists of a lipid bilayer with"/>
  <result pre="viral envelope of IAV consists of a lipid bilayer with" exact="viral" post="transmembrane proteins called HA, NA and M2. HA recognizes"/>
  <result pre="receptors expressed on the surface of host cells in the" exact="respiratory" post="tract and is responsible for viral attachment and entry."/>
  <result pre="host cells in the respiratory tract and is responsible for" exact="viral" post="attachment and entry. M2 is a proton-selective ion channel"/>
  <result pre="endocytosis and endosomal acidification. It mediates the acidification of the" exact="viral" post="core via the introduction of protons and results in"/>
  <result pre="cells. It cleaves the SIA residues of glycoproteins to allow" exact="viral" post="release and to prevent aggregation of individual virions [20]."/>
  <result pre="of HA and NA. Antigenic drift and antigenic shift, the" exact="primary" post="mechanisms behind the antigenic variation of the influenza virus,"/>
  <result pre="successful infection, the influenza virus must first pass through the" exact="respiratory" post="mucus layer that forms a primary physical barrier. Mucus"/>
  <result pre="first pass through the respiratory mucus layer that forms a" exact="primary" post="physical barrier. Mucus in the respiratory tract contains sialylated"/>
  <result pre="layer that forms a primary physical barrier. Mucus in the" exact="respiratory" post="tract contains sialylated glycoproteins. Previous research has demonstrated that"/>
  <result pre="expressed in the airway mucus protect the underlying cells from" exact="infection" post="by inhibiting viral entry [26]. However, the influenza virus"/>
  <result pre="airway mucus protect the underlying cells from infection by inhibiting" exact="viral" post="entry [26]. However, the influenza virus cleaves sialylated mucins"/>
  <result pre="enter the host cell via receptor-mediated endocytosis. However, SIA-independent influenza" exact="infection" post="has also been reported [27,28]. C-type lectin receptors are"/>
  <result pre="receptors are thought to act as alternative receptors that allow" exact="infectious" post="entry of the influenza virus in a manner independent"/>
  <result pre="galactose-type lectin and mannose receptors play important roles in influenza" exact="infection" post="[29,30,31]. DC-SIGN (DC209) and L-SIGN (CD209L) have been identified"/>
  <result pre="at which the virus infects dendritic cells (DCs) isolated from" exact="peripheral" post="blood mononuclear cells [32]. These results suggest that C-type"/>
  <result pre="proton channels mediate endosomal acidification, resulting in the fusion of" exact="viral" post="and endosomal membranes and the release of vRNPs into"/>
  <result pre="nucleus via nuclear pore complexes, where they transcribe and replicate" exact="viral" post="RNA (vRNA). RNA-dependent RNA polymerase (RdRP) is responsible for"/>
  <result pre="(RdRP) is responsible for both transcription and replication of the" exact="viral" post="RNA genome. The influenza RdRP protein consists of three"/>
  <result pre="Specifically, a â€œcap-snatchingâ€� mechanism is required for the transcription of" exact="viral" post="mRNA. PB2 recognizes the 5â€² cap of host pre-mRNA,"/>
  <result pre="RNA fragments that are then used as primers to initiate" exact="viral" post="mRNA transcription [41,42]. PB1 carries out viral mRNA synthesis"/>
  <result pre="primers to initiate viral mRNA transcription [41,42]. PB1 carries out" exact="viral" post="mRNA synthesis using these short fragments [43,44]. In contrast,"/>
  <result pre="transcription [41,42]. PB1 carries out viral mRNA synthesis using these" exact="short" post="fragments [43,44]. In contrast, vRNA replication, which occurs through"/>
  <result pre="and the cap-dependent endonuclease inhibitor targets influenza polymerase to prevent" exact="viral" post="replication. While these drugs are currently effective, constant changes"/>
  <result pre="While these drugs are currently effective, constant changes in the" exact="viral" post="genome cause drug resistance and reduce therapeutic efficacy (Figure"/>
  <result pre="Virus After entering the host, the influenza virus infects bronchiolar-alveolar" exact="epithelial" post="cells lining the respiratory tract and replicates to spread"/>
  <result pre="host, the influenza virus infects bronchiolar-alveolar epithelial cells lining the" exact="respiratory" post="tract and replicates to spread throughout the airways [62]."/>
  <result pre="results in the expression and secretion of proinflammatory cytokines and" exact="type I" post="IFNs, which establish an antiviral immune microenvironment. 3.1. TLRs"/>
  <result pre="dsRNA during replication [63,64], TLR3 activation can occur during influenza" exact="infection" post="[65]. However, the specific TLR3 ligand that is produced"/>
  <result pre="However, the specific TLR3 ligand that is produced during IAV" exact="infection" post="has not yet been determined. The resulting TLR3 signaling"/>
  <result pre="resulting TLR3 signaling process induces production of proinflammatory cytokines and" exact="type I" post="IFN via Toll/IL-1 receptor-domain-containing adapter-inducing interferon-Î² (TRIF)-mediated activation of"/>
  <result pre="of proinflammatory cytokines in the bronchoalveolar airspace and contributes to" exact="viral" post="pathology during H3N2 infection, and viral burden is increased"/>
  <result pre="airspace and contributes to viral pathology during H3N2 infection, and" exact="viral" post="burden is increased in the lungs of TLR3 knockout"/>
  <result pre="because T and B cell responses are unaffected by TLR3" exact="deficiency" post="[68]. TLR7, the receptor for single-stranded RNA (ssRNA), is"/>
  <result pre="detection of ssRNA by TLR7 can occur prior to actual" exact="viral" post="replication in pDCs [70]. TLR7 signaling induces the activation"/>
  <result pre="MyD88-mediated pathway, which initiates the expression of proinflammatory cytokines and" exact="type I" post="IFNs. Due to conflicting results from previous studies, it"/>
  <result pre="is necessary for the protection against influenza infection. However, TLR7" exact="deficiency" post="results in attenuated production of type I IFN by"/>
  <result pre="influenza infection. However, TLR7 deficiency results in attenuated production of" exact="type I" post="IFN by pDCs [69], reduced IL-1Î² secretion from bone"/>
  <result pre="of IFN-Î³ by lung natural killer cells (NK cells) during" exact="infection" post="[72], suggesting that TLR7 is responsible for efficient innate"/>
  <result pre="humoral responses [68,73,74,75,76]. 3.2. RIG-I Signaling Pathway RIG-I is a" exact="cytosolic" post="sensor of short viral 5â€²-triphosphorylated ssRNA or dsRNA. The"/>
  <result pre="3.2. RIG-I Signaling Pathway RIG-I is a cytosolic sensor of" exact="short" post="viral 5â€²-triphosphorylated ssRNA or dsRNA. The 5â€™-triphosphate-containing vRNA that"/>
  <result pre="RIG-I Signaling Pathway RIG-I is a cytosolic sensor of short" exact="viral" post="5â€²-triphosphorylated ssRNA or dsRNA. The 5â€™-triphosphate-containing vRNA that is"/>
  <result pre="ssRNA or dsRNA. The 5â€™-triphosphate-containing vRNA that is produced during" exact="viral" post="replication is recognized by RIG-I. RIG-I uses its helicase"/>
  <result pre="NF-ÎºB, which then initiates the production of proinflammatory cytokines and" exact="type I" post="IFNs. Although replication of the influenza virus occurs in"/>
  <result pre="this stress granule serves as the site for detection of" exact="viral" post="ssRNA by RIG-I. Of note, the influenza virus actually"/>
  <result pre="seem to play a critical role in the defense against" exact="viral infection;" post="survival and adaptive immune responses against the influenza virus"/>
  <result pre="crucial role for the inflammasome in cellular defense against influenza" exact="virus infection." post="Inflammasome-deficient mice have impaired recruitment of monocytes and granulocytes"/>
  <result pre="and granulocytes to the lung and suffer from significantly increased" exact="disease" post="severity compared to control mice. Although inflammasome deficiency did"/>
  <result pre="significantly increased disease severity compared to control mice. Although inflammasome" exact="deficiency" post="did not affect viral clearance within the first 6"/>
  <result pre="compared to control mice. Although inflammasome deficiency did not affect" exact="viral" post="clearance within the first 6 days after infection, late"/>
  <result pre="viral clearance within the first 6 days after infection, late" exact="viral" post="clearance (7â€&quot;10 days post-infection) was significantly decreased by inflammasome"/>
  <result pre="viral clearance (7â€&quot;10 days post-infection) was significantly decreased by inflammasome" exact="deficiency" post="[83,84,85]. Prior work has shown that the inflammasome plays"/>
  <result pre="cell responses against the influenza virus during low dose infection;" exact="deficiency" post="of the inflammasome adaptor protein ASC and the downstream"/>
  <result pre="immune responses [85]. 3.4. cGAS-STING Pathway cGAS is a well-known" exact="cytosolic" post="DNA sensor that mediates cytosolic DNA-induced immune responses though"/>
  <result pre="Pathway cGAS is a well-known cytosolic DNA sensor that mediates" exact="cytosolic" post="DNA-induced immune responses though its downstream signaling molecule, stimulator"/>
  <result pre="signaling molecule, stimulator of interferon genes (STING) [86]. Accumulation of" exact="cytosolic" post="DNA triggers activation of cGAS-STING, resulting in the production"/>
  <result pre="DNA triggers activation of cGAS-STING, resulting in the production of" exact="type I" post="IFN and inflammatory cytokines through activation of IRF3 and"/>
  <result pre="through activation of IRF3 and NF-ÎºB. Self-DNA, mitochondrial DNA (mtDNA)," exact="viral" post="DNA, and bacterial DNAs are known ligands of cGAS"/>
  <result pre="IRF3 and NF-ÎºB. Self-DNA, mitochondrial DNA (mtDNA), viral DNA, and" exact="bacterial" post="DNAs are known ligands of cGAS [86,87,88,89,90,91]. It is"/>
  <result pre="important role in the defense against DNA viruses including the" exact="herpes" post="simplex virus [92]. Interestingly, a recent study has revealed"/>
  <result pre="simplex virus [92]. Interestingly, a recent study has revealed that" exact="infection" post="with influenza, an RNA virus, also activates the cGAS-STING"/>
  <result pre="RNA virus, also activates the cGAS-STING pathway [93]. After influenza" exact="virus infection," post="the M2 protein promotes the release of mtDNA into"/>
  <result pre="the cGAS-STING pathway is crucial for host survival after influenza" exact="virus infection." post="4. Innate Effector Cell Types in the Response to"/>
  <result pre="4. Innate Effector Cell Types in the Response to Influenza" exact="Infection" post="During influenza virus infections, innate signaling and adaptive immune"/>
  <result pre="play important roles in protecting against the virus and achieving" exact="viral" post="clearance. At the site of infection, infected cells produce"/>
  <result pre="of infection, infected cells produce chemokines and cytokines such as" exact="type I" post="IFNs, IL-6, IL-8, TNF-Î±, CCL2 (MCP-1), RANTES, and MIP-1Î±"/>
  <result pre="NK cells, neutrophils, macrophages and DCs to the site of" exact="infection" post="where they initiate the innate immune response [94,95,96]. These"/>
  <result pre="cells are responsible for both protection and immunopathology following influenza" exact="virus infection." post="4.1. Natural Killer Cells, Neutrophils, and Macrophages Innate cells"/>
  <result pre="Macrophages Innate cells are initially recruited to the site of" exact="infection" post="from the systemic circulation by the proinflammatory cytokines that"/>
  <result pre="are initially recruited to the site of infection from the" exact="systemic" post="circulation by the proinflammatory cytokines that are released by"/>
  <result pre="by the proinflammatory cytokines that are released by infected lung" exact="epithelial" post="cells. NK cells recognize HA on influenza-infected cells via"/>
  <result pre="and granzyme [101,102]. Defects in NK cells lead to increased" exact="susceptibility to" post="influenza infection and uncontrolled viral growth in the lungs"/>
  <result pre="Defects in NK cells lead to increased susceptibility to influenza" exact="infection" post="and uncontrolled viral growth in the lungs [103,104]. However,"/>
  <result pre="NK cells lead to increased susceptibility to influenza infection and" exact="uncontrolled" post="viral growth in the lungs [103,104]. However, excessive NK"/>
  <result pre="cells lead to increased susceptibility to influenza infection and uncontrolled" exact="viral" post="growth in the lungs [103,104]. However, excessive NK cell-induced"/>
  <result pre="inflammation can also contribute to pathology following high dose influenza" exact="virus infection" post="[105,106]. Neutrophils, monocytes, and macrophages inhibit the spread of"/>
  <result pre="can also contribute to pathology following high dose influenza virus" exact="infection" post="[105,106]. Neutrophils, monocytes, and macrophages inhibit the spread of"/>
  <result pre="infection [105,106]. Neutrophils, monocytes, and macrophages inhibit the spread of" exact="infection" post="by phagocytosing infected apoptotic cells [107]. Neutrophils rapidly migrate"/>
  <result pre="apoptotic cells [107]. Neutrophils rapidly migrate to the site of" exact="infection" post="and initiate phagocytosis, degranulation, and the formation of neutrophil"/>
  <result pre="neutrophil depletion leads to increased influenza mortality due to impaired" exact="viral" post="clearance [109,110]. Neutropenic mice display reduced flu-specific CD8+ T"/>
  <result pre="mice display reduced flu-specific CD8+ T cell responses in the" exact="respiratory" post="tract [111]. Further to this, neutrophils guide CD8+ T"/>
  <result pre="Further to this, neutrophils guide CD8+ T cells to the" exact="infection" post="site by leaving a trail of CXCL12 [112]. These"/>
  <result pre="excessive recruitment of neutrophils can also contribute to immunopathology [113]." exact="Alveolar" post="macrophages (AMs) are lung-resident macrophages that control lung homeostasis"/>
  <result pre="infected cells [114]. AMs are also the main producer of" exact="type I" post="IFN in the lung during infection with RNA viruses"/>
  <result pre="main producer of type I IFN in the lung during" exact="infection" post="with RNA viruses [115]. There are several lines of"/>
  <result pre="depletion of AMs increases the mortality of mice and enhances" exact="pulmonary" post="inflammation during influenza infection [116]. Csf2âˆ’/âˆ’ mice, which are"/>
  <result pre="the mortality of mice and enhances pulmonary inflammation during influenza" exact="infection" post="[116]. Csf2âˆ’/âˆ’ mice, which are deficient in AM development,"/>
  <result pre="[116]. Csf2âˆ’/âˆ’ mice, which are deficient in AM development, experience" exact="respiratory" post="failure and reduced resistance to influenza infection despite having"/>
  <result pre="AM development, experience respiratory failure and reduced resistance to influenza" exact="infection" post="despite having normal adaptive immune responses against influenza virus"/>
  <result pre="to aggressive inflammatory responses and severe lung pathology after influenza" exact="infection" post="[118]. AMs control lung dysfunction by increasing the antiviral"/>
  <result pre="lung dysfunction by increasing the antiviral resistance of type-1 alveolar" exact="epithelial" post="cells, which are responsible for gas exchange [119]. These"/>
  <result pre="results indicate that AMs play a crucial role in maintaining" exact="pulmonary" post="homeostasis during influenza infection. 4.2. Dendritic Cells DCs, which"/>
  <result pre="been conducted to clarify the role of DCs during influenza" exact="virus infection." post="CD11c-DTR transgenic mice express a high-affinity diphtheria toxin receptor"/>
  <result pre="during influenza virus infection. CD11c-DTR transgenic mice express a high-affinity" exact="diphtheria" post="toxin receptor (DTR) in CD11c+ cells [120], allowing targeted"/>
  <result pre="[120], allowing targeted depletion of DCs by the administration of" exact="diphtheria" post="toxin (DT). CD11c-DTR mice have been used to study"/>
  <result pre="to study the function of DCs in vivo. Following influenza" exact="virus infection," post="DT-treated mice experience significantly more severe weight loss than"/>
  <result pre="T cell populations are significantly decreased in the lung, and" exact="viral" post="clearance is impaired, suggesting that CD11c+ DCs are responsible"/>
  <result pre="for the activation of CD8+ T cells and T cell-mediated" exact="viral" post="clearance during influenza virus infection. In the lungs, DCs"/>
  <result pre="CD8+ T cells and T cell-mediated viral clearance during influenza" exact="virus infection." post="In the lungs, DCs are classified into migratory conventional"/>
  <result pre="DC subsets have specialized functions in the response to influenza" exact="virus infection." post="Remarkably, respiratory DC subsets display different susceptibility to influenza"/>
  <result pre="specialized functions in the response to influenza virus infection. Remarkably," exact="respiratory" post="DC subsets display different susceptibility to influenza virus infection."/>
  <result pre="to influenza virus infection. Remarkably, respiratory DC subsets display different" exact="susceptibility to" post="influenza virus infection. cDC1 is more susceptible to influenza"/>
  <result pre="infection. Remarkably, respiratory DC subsets display different susceptibility to influenza" exact="virus infection." post="cDC1 is more susceptible to influenza virus infection than"/>
  <result pre="to influenza virus infection. cDC1 is more susceptible to influenza" exact="virus infection" post="than cDC2 and pDCs [126], but influenza infection of"/>
  <result pre="influenza virus infection. cDC1 is more susceptible to influenza virus" exact="infection" post="than cDC2 and pDCs [126], but influenza infection of"/>
  <result pre="influenza virus infection than cDC2 and pDCs [126], but influenza" exact="infection" post="of cDC1 does not lead to productive viral replication"/>
  <result pre="but influenza infection of cDC1 does not lead to productive" exact="viral" post="replication [127]. Following influenza infection, lung-migratory cDCs take up"/>
  <result pre="viral replication [127]. Following influenza infection, lung-migratory cDCs take up" exact="viral" post="antigen and migrate to the draining mediastinal lymph nodes"/>
  <result pre="response. Most studies determining the role of DCs in influenza" exact="virus infection" post="have focused on the cDC1 subset. CD103+ cDC1s are"/>
  <result pre="Most studies determining the role of DCs in influenza virus" exact="infection" post="have focused on the cDC1 subset. CD103+ cDC1s are"/>
  <result pre="this process reaches its peak within 48â€&quot;72 h after influenza" exact="virus infection" post="[130]. There have been several reports that have suggested"/>
  <result pre="process reaches its peak within 48â€&quot;72 h after influenza virus" exact="infection" post="[130]. There have been several reports that have suggested"/>
  <result pre="receptor-expressing cells such as cDC1, are highly susceptible to influenza" exact="virus infection" post="after treatment with DT [129]. These cDC1-depleted mice were"/>
  <result pre="cells such as cDC1, are highly susceptible to influenza virus" exact="infection" post="after treatment with DT [129]. These cDC1-depleted mice were"/>
  <result pre="were unable to recover from weight loss and had severe" exact="pulmonary" post="inflammation and lung damage. In addition to reductions in"/>
  <result pre="in lymph nodes that drain from the lungs during influenza" exact="virus infection," post="these cells rarely carried intact viral antigens [127]. Consistently,"/>
  <result pre="lungs during influenza virus infection, these cells rarely carried intact" exact="viral" post="antigens [127]. Consistently, migratory cDC2s are less efficient at"/>
  <result pre="role of cDC1s and cDC2s in the response to influenza" exact="virus infection." post="pDCs, which are primarily known as producers of type"/>
  <result pre="virus infection. pDCs, which are primarily known as producers of" exact="type I" post="IFNs [138], seem to play a minor role in"/>
  <result pre="to play a minor role in the defense against influenza" exact="virus infection." post="Despite the accumulation of pDCs in the lung following"/>
  <result pre="Despite the accumulation of pDCs in the lung following influenza" exact="virus infection," post="pDC-depleted mice showed identical survival rate and body weight"/>
  <result pre="affect body weight loss, effector CD8+ T cell responses, or" exact="viral" post="clearance after influenza virus infection in mice [121]. Consistently,"/>
  <result pre="effector CD8+ T cell responses, or viral clearance after influenza" exact="virus infection" post="in mice [121]. Consistently, both wild-type and pDC-deficient IkarosL/L"/>
  <result pre="CD8+ T cell responses, or viral clearance after influenza virus" exact="infection" post="in mice [121]. Consistently, both wild-type and pDC-deficient IkarosL/L"/>
  <result pre="both wild-type and pDC-deficient IkarosL/L mice showed comparable weight loss," exact="viral" post="burden in lung, influenza virus-specific antibody production, and lung"/>
  <result pre="in lung, influenza virus-specific antibody production, and lung pathology following" exact="viral infection" post="[139]. However, there is some evidence that pDCs may"/>
  <result pre="lung, influenza virus-specific antibody production, and lung pathology following viral" exact="infection" post="[139]. However, there is some evidence that pDCs may"/>
  <result pre="T cells [140,141]. Although the role of MoDCs during influenza" exact="virus infection" post="has not been well established, it has been reported"/>
  <result pre="cells [140,141]. Although the role of MoDCs during influenza virus" exact="infection" post="has not been well established, it has been reported"/>
  <result pre="induce the robust production of nitric oxide synthase 2, and" exact="deficiency" post="in CCR2 leads to attenuation in weight loss, pulmonary"/>
  <result pre="and deficiency in CCR2 leads to attenuation in weight loss," exact="pulmonary" post="pathology, and mortality after a lethal dose of the"/>
  <result pre="these results indicate that MoDCs are associated with influenza virus-induced" exact="pulmonary" post="pathology. On the other hand, other work has suggested"/>
  <result pre="other work has suggested a protective role for MoDCs during" exact="secondary" post="influenza virus infection [142]. Researchers found that MoDC-deficient CCR2âˆ’/âˆ’"/>
  <result pre="has suggested a protective role for MoDCs during secondary influenza" exact="virus infection" post="[142]. Researchers found that MoDC-deficient CCR2âˆ’/âˆ’ mice displayed an"/>
  <result pre="suggested a protective role for MoDCs during secondary influenza virus" exact="infection" post="[142]. Researchers found that MoDC-deficient CCR2âˆ’/âˆ’ mice displayed an"/>
  <result pre="displayed an impairment of antigen-specific CD8+ T cell formation following" exact="primary" post="influenza challenge, and lack of MoDCs during primary influenza"/>
  <result pre="formation following primary influenza challenge, and lack of MoDCs during" exact="primary" post="influenza infection reduced host resistance to secondary virus infection,"/>
  <result pre="primary influenza challenge, and lack of MoDCs during primary influenza" exact="infection" post="reduced host resistance to secondary virus infection, suggesting that"/>
  <result pre="of MoDCs during primary influenza infection reduced host resistance to" exact="secondary" post="virus infection, suggesting that MoDCs could be considered as"/>
  <result pre="MoDCs during primary influenza infection reduced host resistance to secondary" exact="virus infection," post="suggesting that MoDCs could be considered as putative targets"/>
  <result pre="of influenza vaccine. 5. Protective Adaptive Immune Responses against Influenza" exact="Infections" post="Although innate immunity contributes to early viral control, adaptive"/>
  <result pre="Responses against Influenza Infections Although innate immunity contributes to early" exact="viral" post="control, adaptive immune responses are crucial for eventual viral"/>
  <result pre="early viral control, adaptive immune responses are crucial for eventual" exact="viral" post="clearance, recovery, and protection from reinfection. As expected, immunodeficient"/>
  <result pre="response [143,144]. In particular, the HA and NA proteins are" exact="primary" post="targets of protective immunity. 5.1. CD4+ Helper T Cell"/>
  <result pre="CD4+ Helper T Cell Response NaÃ¯ve CD4+ cells recognize the" exact="viral" post="antigens presented by the major histocompatibility complex (MHC) class"/>
  <result pre="CD4+ T cell responses peak at 10 days after influenza" exact="infection" post="in the mouse lung [145]. Adaptive transfer of effector"/>
  <result pre="after influenza challenge [145]. The cytokine milieu generated during influenza" exact="virus infection" post="is polarized to support the generation of Th1 cells"/>
  <result pre="influenza challenge [145]. The cytokine milieu generated during influenza virus" exact="infection" post="is polarized to support the generation of Th1 cells"/>
  <result pre="of Th1 cells [146]. Th1 cells produce IFN-Î³, IL-2, and" exact="tumor" post="necrosis factor Î± (TNFÎ±). These cytokines activate macrophages, promote"/>
  <result pre="cellular immune responses. Th2 responses are also induced following influenza" exact="virus infection." post="Th2 cells secrete IL-4, IL-5, and IL-13 and promote"/>
  <result pre="Th1 cells are more closely associated with survival after influenza" exact="virus infection" post="compared with Th2 cells [148]. Some CD4+ T cell"/>
  <result pre="cells are more closely associated with survival after influenza virus" exact="infection" post="compared with Th2 cells [148]. Some CD4+ T cell"/>
  <result pre="show evidence of perforin/granzyme-mediated cytolytic activity [146,149,150]. In addition, IAV" exact="infection" post="leads to robust regulatory T cells (Tregs) that mediate"/>
  <result pre="play an important role in host protection during and after" exact="infection" post="with the influenza virus. 5.2. Cytotoxic CD8+ T Cell"/>
  <result pre="CD8+ T Cell Response CD8+ T cells are important for" exact="viral" post="clearance and host protection during influenza virus infection. CD8+"/>
  <result pre="are important for viral clearance and host protection during influenza" exact="virus infection." post="CD8+ T cells recognize viral antigens loaded onto MHC"/>
  <result pre="host protection during influenza virus infection. CD8+ T cells recognize" exact="viral" post="antigens loaded onto MHC class I proteins on the"/>
  <result pre="loaded onto MHC class I proteins on the surface of" exact="viral" post="antigen-presenting cells. CD8+ responses reach a maximum at 8"/>
  <result pre="cells. CD8+ responses reach a maximum at 8 days after" exact="infection" post="in the draining mLN and at 10 days post-infection"/>
  <result pre="[121,154]. Î²2-Microglobulin-deficient mice, which lack CD8+ T cells, display delayed" exact="viral" post="clearance and severe mortality following influenza virus infection [155]."/>
  <result pre="cells, display delayed viral clearance and severe mortality following influenza" exact="virus infection" post="[155]. Activated cytotoxic CD8+ T cells (CTLs) eliminate virus-infected"/>
  <result pre="display delayed viral clearance and severe mortality following influenza virus" exact="infection" post="[155]. Activated cytotoxic CD8+ T cells (CTLs) eliminate virus-infected"/>
  <result pre="in the lung produce IFN-Î³ and TNFÎ±, which contribute to" exact="viral" post="defense mechanisms [158,159,160]. Remarkably, IL-10 is also produced by"/>
  <result pre="CD8+ T cells and is responsible for the regulation of" exact="pulmonary" post="inflammation during the response to influenza virus infections. Previous"/>
  <result pre="the influenza virus [161]. Further, blockade of IL-10 signaling increases" exact="pulmonary" post="inflammation and lethal injury following sublethal influenza virus challenge"/>
  <result pre="response has been extensively studied in recent years. During influenza" exact="virus infection," post="naÃ¯ve B cells in the mLNs encounter the influenza"/>
  <result pre="(AFCs). B lymphocyte-deficient Î¼MT mice are more susceptible to influenza" exact="virus infection" post="compared to wild-type mice [162,163]. The B cell response"/>
  <result pre="B lymphocyte-deficient Î¼MT mice are more susceptible to influenza virus" exact="infection" post="compared to wild-type mice [162,163]. The B cell response"/>
  <result pre="to secrete anti-influenza virus IgG by day 7 [164]. The" exact="total" post="number of B cells in BALF peaks around 10"/>
  <result pre="the lung produce IgG and IgM, but AFCs in the" exact="upper" post="respiratory tract primarily produce IgA [165]. Systemic AFCs are"/>
  <result pre="lung produce IgG and IgM, but AFCs in the upper" exact="respiratory" post="tract primarily produce IgA [165]. Systemic AFCs are first"/>
  <result pre="AFCs in the upper respiratory tract primarily produce IgA [165]." exact="Systemic" post="AFCs are first detected 6â€&quot;7 days after infection. Antibodies"/>
  <result pre="important for protective immunity because these proteins are responsible for" exact="viral" post="entry and release. HA-specific antibodies bind to the HA"/>
  <result pre="virus to the host cellâ€™s surface [166,167,168]. This mechanism of" exact="viral" post="inactivation is called neutralization. NA-specific antibodies do not neutralize"/>
  <result pre="NA-specific antibodies do not neutralize the virus, but instead block" exact="viral" post="replication by inhibiting the enzymatic activity of NA [156,169]."/>
  <result pre="specific antibodies. Passive transfer of M2-specific antibodies provide protection against" exact="viral" post="replication [170]. Surprisingly, NP-specific antibodies are protective in nature"/>
  <result pre="NP-specific antibodies are protective in nature despite having an internal" exact="viral" post="protein as their target [171]. In addition to the"/>
  <result pre="IgM, independent of antigenic priming, contribute to protection against influenza" exact="virus infection." post="Natural IgM in the airway has neutralizing activity and"/>
  <result pre="a major annual public health burden. Further, the average annual" exact="total" post="economic burden of influenza has been estimated at $11.2"/>
  <result pre="year [175]. Considerable efforts have been devoted to reducing the" exact="disease" post="burden of influenza. Vaccination remains the best way to"/>
  <result pre="upcoming flu season, and vaccination can provide effective protection against" exact="viral infection." post="However, because influenza viruses constantly change their antigens to"/>
  <result pre="of influenza viruses. The lack of proofreading ability in the" exact="viral" post="RNA polymerase results in high mutation rates and the"/>
  <result pre="are currently effective, a shifting pattern of changes in the" exact="viral" post="genome can cause drug resistance and corresponding reductions in"/>
  <result pre="The authors declare that the research was conducted in the" exact="absence of" post="any commercial or financial relationships that could be construed"/>
  <result pre="D in Italy: Towards a better understanding of an emerging" exact="viral infection" post="in swineSci. Rep.201771166010.1038/s41598-017-12012-328916759 12.WhiteS.K.MaW.McDanielC.J.GrayG.C.LednickyJ.A.Serologic evidence of exposure to influenza"/>
  <result pre="in Italy: Towards a better understanding of an emerging viral" exact="infection" post="in swineSci. Rep.201771166010.1038/s41598-017-12012-328916759 12.WhiteS.K.MaW.McDanielC.J.GrayG.C.LednickyJ.A.Serologic evidence of exposure to influenza"/>
  <result pre="Influenza B VirusesViruses20191173610.3390/v1108073631404985 15.Gutierrez-PizarrayaA.Perez-RomeroP.AlvarezR.AydilloT.A.Osorio-GomezG.Milara-IbanezC.SanchezM.PachonJ.CorderoE.Unexpected severity of cases of influenza B" exact="infection" post="in patients that required hospitalization during the first postpandemic"/>
  <result pre="of the influenza virus M1 protein in nuclear export of" exact="viral" post="ribonucleoproteinsJ. Virol.2000741781178610.1128/JVI.74.4.1781-1786.200010644350 20.PaleseP.TobitaK.UedaM.CompansR.W.Characterization of temperature sensitive influenza virus mutants"/>
  <result pre="Yin(-)Yang Proteins Coevolving to Thwart ImmunityViruses20191134610.3390/v1104034631014029 22.SamjiT.Influenza A: Understanding the" exact="viral" post="life cycleYale J. Biol. Med.20098215315920027280 23.IwasakiA.PillaiP.S.Innate immunity to influenza"/>
  <result pre="virus infectionNat. Rev. Immunol.20141431532810.1038/nri366524762827 24.SubbaraoK.JosephT.Scientific barriers to developing vaccines against" exact="avian influenza" post="virusesNat. Rev. Immunol.2007726727810.1038/nri205417363960 25.NelsonM.I.HolmesE.C.The evolution of epidemic influenzaNat. Rev."/>
  <result pre="host mucus by cleaving sialic acids with neuraminidaseVirol. J.20131032110.1186/1743-422X-10-32124261589 27.StrayS.J.CummingsR.D.AirG.M.Influenza" exact="virus infection" post="of desialylated cellsGlycobiology20001064965810.1093/glycob/10.7.64910910970 28.ThompsonC.I.BarclayW.S.ZambonM.C.PicklesR.J.Infection of human airway epithelium by"/>
  <result pre="mucus by cleaving sialic acids with neuraminidaseVirol. J.20131032110.1186/1743-422X-10-32124261589 27.StrayS.J.CummingsR.D.AirG.M.Influenza virus" exact="infection" post="of desialylated cellsGlycobiology20001064965810.1093/glycob/10.7.64910910970 28.ThompsonC.I.BarclayW.S.ZambonM.C.PicklesR.J.Infection of human airway epithelium by"/>
  <result pre="influenza a virusJ. Virol.2006808060806810.1128/JVI.00384-0616873262 29.ReadingP.C.MillerJ.L.AndersE.M.Involvement of the mannose receptor in" exact="infection" post="of macrophages by influenza virusJ. Virol.2000745190519710.1128/JVI.74.11.5190-5197.200010799594 30.UphamJ.P.PickettD.IrimuraT.AndersE.M.ReadingP.C.Macrophage receptors for"/>
  <result pre="Role of the macrophage galactose-type lectin and mannose receptor in" exact="viral" post="entryJ. Virol.2010843730373710.1128/JVI.02148-0920106926 31.NgW.C.LiongS.TateM.D.IrimuraT.Denda-NagaiK.BrooksA.G.LondriganS.L.ReadingP.C.The macrophage galactose-type lectin can function as"/>
  <result pre="expressing DC-SIGN or L-SIGNJ. Virol.2011852990300010.1128/JVI.01705-1021191006 34.WangS.F.HuangJ.C.LeeY.M.LiuS.J.ChanY.J.ChauY.P.ChongP.ChenY.M.DC-SIGN mediates avian H5N1 influenza" exact="virus infection" post="in cis and in transBiochem. Biophys. Res. Commun.200837356156610.1016/j.bbrc.2008.06.07818593570 35.GillespieL.RoosendahlP.NgW.C.BrooksA.G.ReadingP.C.LondriganS.L.Endocytic"/>
  <result pre="DC-SIGN or L-SIGNJ. Virol.2011852990300010.1128/JVI.01705-1021191006 34.WangS.F.HuangJ.C.LeeY.M.LiuS.J.ChanY.J.ChauY.P.ChongP.ChenY.M.DC-SIGN mediates avian H5N1 influenza virus" exact="infection" post="in cis and in transBiochem. Biophys. Res. Commun.200837356156610.1016/j.bbrc.2008.06.07818593570 35.GillespieL.RoosendahlP.NgW.C.BrooksA.G.ReadingP.C.LondriganS.L.Endocytic"/>
  <result pre="Biophys. Res. Commun.200837356156610.1016/j.bbrc.2008.06.07818593570 35.GillespieL.RoosendahlP.NgW.C.BrooksA.G.ReadingP.C.LondriganS.L.Endocytic function is critical for influenza A" exact="virus infection" post="via DC-SIGN and L-SIGNSci. Rep.201661942810.1038/srep1942826763587 36.Stencel-BaerenwaldJ.E.ReissK.ReiterD.M.StehleT.DermodyT.S.The sweet spot: Defining"/>
  <result pre="Res. Commun.200837356156610.1016/j.bbrc.2008.06.07818593570 35.GillespieL.RoosendahlP.NgW.C.BrooksA.G.ReadingP.C.LondriganS.L.Endocytic function is critical for influenza A virus" exact="infection" post="via DC-SIGN and L-SIGNSci. Rep.201661942810.1038/srep1942826763587 36.Stencel-BaerenwaldJ.E.ReissK.ReiterD.M.StehleT.DermodyT.S.The sweet spot: Defining"/>
  <result pre="recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating" exact="viral" post="RNA transcriptionProc. Natl. Acad. Sci. USA1981787355735910.1073/pnas.78.12.73556950380 45.PflugA.LukarskaM.Resa-InfanteP.ReichS.CusackS.Structural insights into"/>
  <result pre="al.Structures of influenza A virus RNA polymerase offer insight into" exact="viral" post="genome replicationNature201957328729010.1038/s41586-019-1530-731485076 47.EgorovA.BrandtS.SereinigS.RomanovaJ.FerkoB.KatingerD.GrassauerA.AlexandrovaG.KatingerH.MusterT.Transfectant influenza A viruses with long deletions"/>
  <result pre="Microbiol.201941671167910.1038/s41564-019-0482-x31263181 53.MoriyamaM.ChenI.Y.KawaguchiA.KoshibaT.NagataK.TakeyamaH.HasegawaH.IchinoheT.The RNA- and TRIM25-Binding Domains of Influenza Virus NS1" exact="Protein" post="Are Essential for Suppression of NLRP3 Inflammasome-Mediated Interleukin-1beta SecretionJ."/>
  <result pre="RNA- and TRIM25-Binding Domains of Influenza Virus NS1 Protein Are" exact="Essential" post="for Suppression of NLRP3 Inflammasome-Mediated Interleukin-1beta SecretionJ. Virol.2016904105411410.1128/JVI.00120-1626865721 54.RuckleA.HaasbachE.JulkunenI.PlanzO.EhrhardtC.LudwigS.The"/>
  <result pre="the noncanonical NF-kappaB pathway and p52/RelB-dependent gene expression in lung" exact="epithelial" post="cellsJ. Virol.201286102111021710.1128/JVI.00323-1222787206 55.GackM.U.AlbrechtR.A.UranoT.InnK.S.HuangI.C.CarneroE.FarzanM.InoueS.JungJ.U.Garcia-SastreA.Influenza A virus NS1 targets the ubiquitin"/>
  <result pre="the ubiquitin ligase TRIM25 to evade recognition by the host" exact="viral" post="RNA sensor RIG-ICell Host Microbe2009543944910.1016/j.chom.2009.04.00619454348 56.MibayashiM.Martinez-SobridoL.LooY.M.CardenasW.B.GaleM.Jr.Garcia-SastreA.Inhibition of retinoic acid-inducible"/>
  <result pre="influenza virus NEP (NS2 protein) mediates the nuclear export of" exact="viral" post="ribonucleoproteinsEMBO J.19981728829610.1093/emboj/17.1.2889427762 60.GoraiT.GotoH.NodaT.WatanabeT.Kozuka-HataH.OyamaM.TakanoR.NeumannG.WatanabeS.KawaokaY.F1Fo-ATPase, F-type proton-translocating ATPase, at the plasma"/>
  <result pre="to severe pathophysiology and diseasePLoS Pathog.20139e100339210.1371/journal.ppat.100339223737748 62.JungH.E.OhJ.E.LeeH.K.Cell-Penetrating Mx1 Enhances Anti-Viral" exact="Resistance" post="against Mucosal Influenza Viral InfectionViruses20191110910.3390/v1102010930696001 63.WisskirchenC.LudersdorferT.H.MullerD.A.MoritzE.PavlovicJ.The cellular RNA helicase"/>
  <result pre="pathophysiology and diseasePLoS Pathog.20139e100339210.1371/journal.ppat.100339223737748 62.JungH.E.OhJ.E.LeeH.K.Cell-Penetrating Mx1 Enhances Anti-Viral Resistance against" exact="Mucosal" post="Influenza Viral InfectionViruses20191110910.3390/v1102010930696001 63.WisskirchenC.LudersdorferT.H.MullerD.A.MoritzE.PavlovicJ.The cellular RNA helicase UAP56 is"/>
  <result pre="diseasePLoS Pathog.20139e100339210.1371/journal.ppat.100339223737748 62.JungH.E.OhJ.E.LeeH.K.Cell-Penetrating Mx1 Enhances Anti-Viral Resistance against Mucosal Influenza" exact="Viral" post="InfectionViruses20191110910.3390/v1102010930696001 63.WisskirchenC.LudersdorferT.H.MullerD.A.MoritzE.PavlovicJ.The cellular RNA helicase UAP56 is required for"/>
  <result pre="bearing 5â€™-phosphatesScience2006314997100110.1126/science.113299817038589 65.Le GofficR.PothlichetJ.VitourD.FujitaT.MeursE.ChignardM.Si-TaharM.Cutting Edge: Influenza A Virus Activates TLR3-Dependent" exact="Inflammatory" post="and RIG-I-Dependent Antiviral Responses in Human Lung Epithelial CellsJ."/>
  <result pre="contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced" exact="acute" post="pneumoniaPLoS Pathog.20062e5310.1371/journal.ppat.002005316789835 68.HeerA.K.ShamshievA.DondaA.UematsuS.AkiraS.KopfM.MarslandB.J.TLR signaling fine-tunes anti-influenza B cell responses"/>
  <result pre="of single-stranded RNAScience20043031529153110.1126/science.109361614976261 70.PangI.K.PillaiP.S.IwasakiA.Efficient influenza A virus replication in the" exact="respiratory" post="tract requires signals from TLR7 and RIG-IProc. Natl. Acad."/>
  <result pre="its intracellular M2 ion channelNat. Immunol.20101140441010.1038/ni.186120383149 72.Stegemann-KoniszewskiS.BehrensS.BoehmeJ.D.HochnadelI.RieseP.GuzmanC.A.KrogerA.SchreiberJ.GunzerM.BruderD.Respiratory Influenza A Virus" exact="Infection" post="Triggers Local and Systemic Natural Killer Cell Activation via"/>
  <result pre="M2 ion channelNat. Immunol.20101140441010.1038/ni.186120383149 72.Stegemann-KoniszewskiS.BehrensS.BoehmeJ.D.HochnadelI.RieseP.GuzmanC.A.KrogerA.SchreiberJ.GunzerM.BruderD.Respiratory Influenza A Virus Infection Triggers" exact="Local" post="and Systemic Natural Killer Cell Activation via Toll-Like Receptor"/>
  <result pre="channelNat. Immunol.20101140441010.1038/ni.186120383149 72.Stegemann-KoniszewskiS.BehrensS.BoehmeJ.D.HochnadelI.RieseP.GuzmanC.A.KrogerA.SchreiberJ.GunzerM.BruderD.Respiratory Influenza A Virus Infection Triggers Local and" exact="Systemic" post="Natural Killer Cell Activation via Toll-Like Receptor 7Front. Immunol.2018924510.3389/fimmu.2018.0024529497422"/>
  <result pre="and RLR-Signaling in the Immune Responses to Influenza A Virus" exact="Infection" post="and VaccinationJ. Immunol.20071794711472010.4049/jimmunol.179.7.471117878370 75.Jeisy-ScottV.KimJ.H.DavisW.G.CaoW.KatzJ.M.SambharaS.TLR7 recognition is dispensable for influenza"/>
  <result pre="VaccinationJ. Immunol.20071794711472010.4049/jimmunol.179.7.471117878370 75.Jeisy-ScottV.KimJ.H.DavisW.G.CaoW.KatzJ.M.SambharaS.TLR7 recognition is dispensable for influenza virus A" exact="infection" post="but important for the induction of hemagglutinin-specific antibodies in"/>
  <result pre="split vaccine in miceJ. Virol.201286109881099810.1128/JVI.01064-1222837197 76.SeoS.U.KwonH.J.SongJ.H.ByunY.H.SeongB.L.KawaiT.AkiraS.KweonM.N.MyD88 signaling is indispensable for" exact="primary" post="influenza A virus infection but dispensable for secondary infectionJ."/>
  <result pre="miceJ. Virol.201286109881099810.1128/JVI.01064-1222837197 76.SeoS.U.KwonH.J.SongJ.H.ByunY.H.SeongB.L.KawaiT.AkiraS.KweonM.N.MyD88 signaling is indispensable for primary influenza A" exact="virus infection" post="but dispensable for secondary infectionJ. Virol.201084127131272210.1128/JVI.01675-1020943980 77.OnomotoK.JogiM.YooJ.S.NaritaR.MorimotoS.TakemuraA.SambharaS.KawaguchiA.OsariS.NagataK.et al.Critical role"/>
  <result pre="Virol.201286109881099810.1128/JVI.01064-1222837197 76.SeoS.U.KwonH.J.SongJ.H.ByunY.H.SeongB.L.KawaiT.AkiraS.KweonM.N.MyD88 signaling is indispensable for primary influenza A virus" exact="infection" post="but dispensable for secondary infectionJ. Virol.201084127131272210.1128/JVI.01675-1020943980 77.OnomotoK.JogiM.YooJ.S.NaritaR.MorimotoS.TakemuraA.SambharaS.KawaguchiA.OsariS.NagataK.et al.Critical role"/>
  <result pre="indispensable for primary influenza A virus infection but dispensable for" exact="secondary" post="infectionJ. Virol.201084127131272210.1128/JVI.01675-1020943980 77.OnomotoK.JogiM.YooJ.S.NaritaR.MorimotoS.TakemuraA.SambharaS.KawaguchiA.OsariS.NagataK.et al.Critical role of an antiviral stress"/>
  <result pre="of an antiviral stress granule containing RIG-I and PKR in" exact="viral" post="detection and innate immunityPLoS ONE20127e4303110.1371/annotation/dcd836ee-9e23-4538-acb7-450560ba5c1d22912779 78.KhaperskyyD.A.HatchetteT.F.McCormickC.Influenza A virus inhibits"/>
  <result pre="of NLRP3 among hematopoietic cellsJ. Immunol.20111862529253410.4049/jimmunol.100272021257968 81.ChungW.C.KangH.R.YoonH.KangS.J.TingJ.P.SongM.J.Influenza A Virus NS1" exact="Protein" post="Inhibits the NLRP3 InflammasomePLoS ONE201510e012645610.1371/journal.pone.012645625978411 82.YoshizumiT.IchinoheT.SasakiO.OteraH.KawabataS.MiharaK.KoshibaT.Influenza A virus protein"/>
  <result pre="vivo innate immunity to influenza A virus through recognition of" exact="viral" post="RNAImmunity20093055656510.1016/j.immuni.2009.02.00519362020 84.ThomasP.G.DashP.AldridgeJ.R.Jr.EllebedyA.H.ReynoldsC.FunkA.J.MartinW.J.LamkanfiM.WebbyR.J.BoydK.L.et al.The intracellular sensor NLRP3 mediates key innate"/>
  <result pre="Rev. Genet.20192065767410.1038/s41576-019-0151-131358977 87.RongvauxA.JacksonR.HarmanC.C.LiT.WestA.P.de ZoeteM.R.WuY.YordyB.LakhaniS.A.KuanC.Y.et al.Apoptotic caspases prevent the induction of" exact="type I" post="interferons by mitochondrial DNACell20141591563157710.1016/j.cell.2014.11.03725525875 88.WhiteM.J.McArthurK.MetcalfD.LaneR.M.CambierJ.C.HeroldM.J.van DelftM.F.BedouiS.LesseneG.RitchieM.E.et al.Apoptotic caspases suppress"/>
  <result pre="by mitochondrial DNACell20141591563157710.1016/j.cell.2014.11.03725525875 88.WhiteM.J.McArthurK.MetcalfD.LaneR.M.CambierJ.C.HeroldM.J.van DelftM.F.BedouiS.LesseneG.RitchieM.E.et al.Apoptotic caspases suppress mtDNA-induced STING-mediated" exact="type I" post="IFN productionCell20141591549156210.1016/j.cell.2014.11.03625525874 89.HansenK.PrabakaranT.LaustsenA.JorgensenS.E.RahbaekS.H.JensenS.B.NielsenR.LeberJ.H.DeckerT.HoranK.A.et al.Listeria monocytogenes induces IFNbeta expression through"/>
  <result pre="cGAS- and STING-dependent pathwayEMBO J.2014331654166610.15252/embj.20148802924970844 90.SunL.WuJ.DuF.ChenX.ChenZ.J.Cyclic GMP-AMP synthase is a" exact="cytosolic" post="DNA sensor that activates the type I interferon pathwayScience201333978679110.1126/science.123245823258413"/>
  <result pre="GMP-AMP synthase is a cytosolic DNA sensor that activates the" exact="type I" post="interferon pathwayScience201333978679110.1126/science.123245823258413 91.MaZ.JacobsS.R.WestJ.A.StopfordC.ZhangZ.DavisZ.BarberG.N.GlaunsingerB.A.DittmerD.P.DamaniaB.Modulation of the cGAS-STING DNA sensing pathway"/>
  <result pre="IFN-alpha enhance influenza-A-virus-induced chemokine gene expression in human A549 lung" exact="epithelial" post="cellsVirology20063459610410.1016/j.virol.2005.09.04316253303 95.WareingM.D.LyonA.InglisC.GiannoniF.CharoI.SarawarS.R.Chemokine regulation of the inflammatory response to a"/>
  <result pre="95.WareingM.D.LyonA.InglisC.GiannoniF.CharoI.SarawarS.R.Chemokine regulation of the inflammatory response to a low-dose influenza" exact="infection" post="in CCR2-/- miceJ. Leukoc. Biol.20078179380110.1189/jlb.050629917179466 96.WareingM.D.LyonA.B.LuB.GerardC.SarawarS.R.Chemokine expression during the"/>
  <result pre="Biol.20078179380110.1189/jlb.050629917179466 96.WareingM.D.LyonA.B.LuB.GerardC.SarawarS.R.Chemokine expression during the development and resolution of a" exact="pulmonary" post="leukocyte response to influenza A virus infection in miceJ."/>
  <result pre="and resolution of a pulmonary leukocyte response to influenza A" exact="virus infection" post="in miceJ. Leukoc. Biol.20047688689510.1189/jlb.120364415240757 97.MandelboimO.LiebermanN.LevM.PaulL.ArnonT.I.BushkinY.DavisD.M.StromingerJ.L.YewdellJ.W.PorgadorA.Recognition of haemagglutinins on virus-infected"/>
  <result pre="resolution of a pulmonary leukocyte response to influenza A virus" exact="infection" post="in miceJ. Leukoc. Biol.20047688689510.1189/jlb.120364415240757 97.MandelboimO.LiebermanN.LevM.PaulL.ArnonT.I.BushkinY.DavisD.M.StromingerJ.L.YewdellJ.W.PorgadorA.Recognition of haemagglutinins on virus-infected"/>
  <result pre="by NKp46 activates lysis by human NK cellsNature20014091055106010.1038/3505911011234016 98.ArnonT.I.LevM.KatzG.ChernobrovY.PorgadorA.MandelboimO.Recognition of" exact="viral" post="hemagglutinins by NKp44 but not by NKp30Eur. J. Immunol.2001312680268910.1002/1521-4141(200109)31:9&amp;lt;2680::AID-IMMU2680&amp;gt;3.0.CO;2-A11536166"/>
  <result pre="O-glycan sequences that are involved in the interaction with hemagglutinin" exact="type 1" post="of influenza virusJ. Virol.2010843789379710.1128/JVI.01815-0920147410 100.JegaskandaS.VandervenH.A.TanH.X.AlcantaraS.WraggK.M.ParsonsM.S.ChungA.W.JunoJ.A.KentS.J.Influenza Virus Infection Enhances Antibody-Mediated"/>
  <result pre="with hemagglutinin type 1 of influenza virusJ. Virol.2010843789379710.1128/JVI.01815-0920147410 100.JegaskandaS.VandervenH.A.TanH.X.AlcantaraS.WraggK.M.ParsonsM.S.ChungA.W.JunoJ.A.KentS.J.Influenza Virus" exact="Infection" post="Enhances Antibody-Mediated NK Cell Functions via Type I Interferon-Dependent"/>
  <result pre="Virol.2010843789379710.1128/JVI.01815-0920147410 100.JegaskandaS.VandervenH.A.TanH.X.AlcantaraS.WraggK.M.ParsonsM.S.ChungA.W.JunoJ.A.KentS.J.Influenza Virus Infection Enhances Antibody-Mediated NK Cell Functions via" exact="Type I" post="Interferon-Dependent PathwaysJ. Virol.20199310.1128/JVI.02090-18 101.HwangI.ScottJ.M.KakarlaT.DuriancikD.M.ChoiS.ChoC.LeeT.ParkH.FrenchA.R.BeliE.et al.Activation mechanisms of natural killer"/>
  <result pre="Immunol.20189167110.3389/fimmu.2018.0167130079068 103.NogusaS.RitzB.W.KassimS.H.JenningsS.R.GardnerE.M.Characterization of age-related changes in natural killer cells during" exact="primary" post="influenza infection in miceMech. Ageing Dev.200812922323010.1016/j.mad.2008.01.00318304606 104.LiuB.MoriI.HossainM.J.DongL.TakedaK.KimuraY.Interleukin-18 improves the"/>
  <result pre="of age-related changes in natural killer cells during primary influenza" exact="infection" post="in miceMech. Ageing Dev.200812922323010.1016/j.mad.2008.01.00318304606 104.LiuB.MoriI.HossainM.J.DongL.TakedaK.KimuraY.Interleukin-18 improves the early defence"/>
  <result pre="Ageing Dev.200812922323010.1016/j.mad.2008.01.00318304606 104.LiuB.MoriI.HossainM.J.DongL.TakedaK.KimuraY.Interleukin-18 improves the early defence system against influenza" exact="virus infection" post="by augmenting natural killer cell-mediated cytotoxicityJ. Gen. Virol.20048542342810.1099/vir.0.19596-014769900 105.ZhouG.JuangS.W.KaneK.P.NK"/>
  <result pre="Dev.200812922323010.1016/j.mad.2008.01.00318304606 104.LiuB.MoriI.HossainM.J.DongL.TakedaK.KimuraY.Interleukin-18 improves the early defence system against influenza virus" exact="infection" post="by augmenting natural killer cell-mediated cytotoxicityJ. Gen. Virol.20048542342810.1099/vir.0.19596-014769900 105.ZhouG.JuangS.W.KaneK.P.NK"/>
  <result pre="cytotoxicityJ. Gen. Virol.20048542342810.1099/vir.0.19596-014769900 105.ZhouG.JuangS.W.KaneK.P.NK cells exacerbate the pathology of influenza" exact="virus infection" post="in miceEur. J. Immunol.20134392993810.1002/eji.20124262023436540 106.Abdul-CareemM.F.MianM.F.YueG.GillgrassA.ChenowethM.J.BarraN.G.ChewM.V.ChanT.Al-GarawiA.A.JordanaM.et al.Critical role of natural"/>
  <result pre="Gen. Virol.20048542342810.1099/vir.0.19596-014769900 105.ZhouG.JuangS.W.KaneK.P.NK cells exacerbate the pathology of influenza virus" exact="infection" post="in miceEur. J. Immunol.20134392993810.1002/eji.20124262023436540 106.Abdul-CareemM.F.MianM.F.YueG.GillgrassA.ChenowethM.J.BarraN.G.ChewM.V.ChanT.Al-GarawiA.A.JordanaM.et al.Critical role of natural"/>
  <result pre="role of natural killer cells in lung immunopathology during influenza" exact="infection" post="in miceJ. Infect. Dis.201220616717710.1093/infdis/jis34022561366 107.HashimotoY.MokiT.TakizawaT.ShiratsuchiA.NakanishiY.Evidence for phagocytosis of influenza"/>
  <result pre="and macrophages in miceJ. Immunol.20071782448245710.4049/jimmunol.178.4.244817277152 108.CampJ.V.JonssonC.B.A Role for Neutrophils in" exact="Viral" post="Respiratory DiseaseFront. Immunol.2017855010.3389/fimmu.2017.0055028553293 109.TumpeyT.M.Garcia-SastreA.TaubenbergerJ.K.PaleseP.SwayneD.E.Pantin-JackwoodM.J.Schultz-CherryS.SolorzanoA.Van RooijenN.KatzJ.M.et al.Pathogenicity of influenza viruses"/>
  <result pre="macrophages in miceJ. Immunol.20071782448245710.4049/jimmunol.178.4.244817277152 108.CampJ.V.JonssonC.B.A Role for Neutrophils in Viral" exact="Respiratory" post="DiseaseFront. Immunol.2017855010.3389/fimmu.2017.0055028553293 109.TumpeyT.M.Garcia-SastreA.TaubenbergerJ.K.PaleseP.SwayneD.E.Pantin-JackwoodM.J.Schultz-CherryS.SolorzanoA.Van RooijenN.KatzJ.M.et al.Pathogenicity of influenza viruses with"/>
  <result pre="mortality in miceJ. Virol.200579149331494410.1128/JVI.79.23.14933-14944.200516282492 110.TateM.D.BrooksA.G.ReadingP.C.The role of neutrophils in the" exact="upper" post="and lower respiratory tract during influenza virus infection of"/>
  <result pre="miceJ. Virol.200579149331494410.1128/JVI.79.23.14933-14944.200516282492 110.TateM.D.BrooksA.G.ReadingP.C.The role of neutrophils in the upper and" exact="lower" post="respiratory tract during influenza virus infection of miceRespir. Res.200895710.1186/1465-9921-9-5718671884"/>
  <result pre="Virol.200579149331494410.1128/JVI.79.23.14933-14944.200516282492 110.TateM.D.BrooksA.G.ReadingP.C.The role of neutrophils in the upper and lower" exact="respiratory" post="tract during influenza virus infection of miceRespir. Res.200895710.1186/1465-9921-9-5718671884 111.TateM.D.BrooksA.G.ReadingP.C.MinternJ.D.Neutrophils"/>
  <result pre="neutrophils in the upper and lower respiratory tract during influenza" exact="virus infection" post="of miceRespir. Res.200895710.1186/1465-9921-9-5718671884 111.TateM.D.BrooksA.G.ReadingP.C.MinternJ.D.Neutrophils sustain effective CD8(+) T-cell responses"/>
  <result pre="in the upper and lower respiratory tract during influenza virus" exact="infection" post="of miceRespir. Res.200895710.1186/1465-9921-9-5718671884 111.TateM.D.BrooksA.G.ReadingP.C.MinternJ.D.Neutrophils sustain effective CD8(+) T-cell responses"/>
  <result pre="miceRespir. Res.200895710.1186/1465-9921-9-5718671884 111.TateM.D.BrooksA.G.ReadingP.C.MinternJ.D.Neutrophils sustain effective CD8(+) T-cell responses in the" exact="respiratory" post="tract following influenza infectionImmunol. Cell Biol.20129019720510.1038/icb.2011.2621483446 112.LimK.HyunY.M.Lambert-EmoK.CapeceT.BaeS.MillerR.TophamD.J.KimM.Neutrophil trails guide"/>
  <result pre="feedforward inflammatory circuit leading to lethal influenza infectionCell201315419721210.1016/j.cell.2013.06.01323827683 114.TrapnellB.C.WhitsettJ.A.Gm-CSF regulates" exact="pulmonary" post="surfactant homeostasis and alveolar macrophage-mediated innate host defenseAnnu. Rev."/>
  <result pre="macrophage-mediated innate host defenseAnnu. Rev. Physiol.20026477580210.1146/annurev.physiol.64.090601.11384711826288 115.KumagaiY.TakeuchiO.KatoH.KumarH.MatsuiK.MoriiE.AozasaK.KawaiT.AkiraS.Alveolar macrophages are the" exact="primary" post="interferon-alpha producer in pulmonary infection with RNA virusesImmunity20072724025210.1016/j.immuni.2007.07.01317723216 116.TateM.D.PickettD.L.van"/>
  <result pre="Rev. Physiol.20026477580210.1146/annurev.physiol.64.090601.11384711826288 115.KumagaiY.TakeuchiO.KatoH.KumarH.MatsuiK.MoriiE.AozasaK.KawaiT.AkiraS.Alveolar macrophages are the primary interferon-alpha producer in" exact="pulmonary" post="infection with RNA virusesImmunity20072724025210.1016/j.immuni.2007.07.01317723216 116.TateM.D.PickettD.L.van RooijenN.BrooksA.G.ReadingP.C.Critical role of airway"/>
  <result pre="Physiol.20026477580210.1146/annurev.physiol.64.090601.11384711826288 115.KumagaiY.TakeuchiO.KatoH.KumarH.MatsuiK.MoriiE.AozasaK.KawaiT.AkiraS.Alveolar macrophages are the primary interferon-alpha producer in pulmonary" exact="infection" post="with RNA virusesImmunity20072724025210.1016/j.immuni.2007.07.01317723216 116.TateM.D.PickettD.L.van RooijenN.BrooksA.G.ReadingP.C.Critical role of airway macrophages"/>
  <result pre="RNA virusesImmunity20072724025210.1016/j.immuni.2007.07.01317723216 116.TateM.D.PickettD.L.van RooijenN.BrooksA.G.ReadingP.C.Critical role of airway macrophages in modulating" exact="disease" post="severity during influenza virus infection of miceJ. Virol.2010847569758010.1128/JVI.00291-1020504924 117.SchneiderC.NobsS.P.HeerA.K.KurrerM.KlinkeG.van"/>
  <result pre="role of airway macrophages in modulating disease severity during influenza" exact="virus infection" post="of miceJ. Virol.2010847569758010.1128/JVI.00291-1020504924 117.SchneiderC.NobsS.P.HeerA.K.KurrerM.KlinkeG.van RooijenN.VogelJ.KopfM.Alveolar macrophages are essential for"/>
  <result pre="of airway macrophages in modulating disease severity during influenza virus" exact="infection" post="of miceJ. Virol.2010847569758010.1128/JVI.00291-1020504924 117.SchneiderC.NobsS.P.HeerA.K.KurrerM.KlinkeG.van RooijenN.VogelJ.KopfM.Alveolar macrophages are essential for"/>
  <result pre="miceJ. Virol.2010847569758010.1128/JVI.00291-1020504924 117.SchneiderC.NobsS.P.HeerA.K.KurrerM.KlinkeG.van RooijenN.VogelJ.KopfM.Alveolar macrophages are essential for protection from" exact="respiratory" post="failure and associated morbidity following influenza virus infectionPLoS Pathog.201410e100405310.1371/journal.ppat.100405324699679"/>
  <result pre="ablation of alveolar macrophages leads to massive pathology of influenza" exact="infection" post="without affecting cellular adaptive immunityEur. J. Immunol.2014442003201210.1002/eji.20134435924687623 119.CardaniA.BoultonA.KimT.S.BracialeT.J.Alveolar Macrophages"/>
  <result pre="without affecting cellular adaptive immunityEur. J. Immunol.2014442003201210.1002/eji.20134435924687623 119.CardaniA.BoultonA.KimT.S.BracialeT.J.Alveolar Macrophages Prevent" exact="Lethal" post="Influenza Pneumonia by Inhibiting Infection Of Type-1 Alveolar Epithelial"/>
  <result pre="cellular adaptive immunityEur. J. Immunol.2014442003201210.1002/eji.20134435924687623 119.CardaniA.BoultonA.KimT.S.BracialeT.J.Alveolar Macrophages Prevent Lethal Influenza" exact="Pneumonia" post="by Inhibiting Infection Of Type-1 Alveolar Epithelial CellsPLoS Pathog.201713e100614010.1371/journal.ppat.100614028085958"/>
  <result pre="J. Immunol.2014442003201210.1002/eji.20134435924687623 119.CardaniA.BoultonA.KimT.S.BracialeT.J.Alveolar Macrophages Prevent Lethal Influenza Pneumonia by Inhibiting" exact="Infection" post="Of Type-1 Alveolar Epithelial CellsPLoS Pathog.201713e100614010.1371/journal.ppat.100614028085958 120.JungS.UnutmazD.WongP.SanoG.De los SantosK.SparwasserT.WuS.VuthooriS.KoK.ZavalaF.et"/>
  <result pre="Macrophages Prevent Lethal Influenza Pneumonia by Inhibiting Infection Of Type-1" exact="Alveolar" post="Epithelial CellsPLoS Pathog.201713e100614010.1371/journal.ppat.100614028085958 120.JungS.UnutmazD.WongP.SanoG.De los SantosK.SparwasserT.WuS.VuthooriS.KoK.ZavalaF.et al.In vivo depletion"/>
  <result pre="allergenImmunity20133832233510.1016/j.immuni.2012.10.01623352232 124.LinK.L.SuzukiY.NakanoH.RamsburgE.GunnM.D.CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced" exact="pulmonary" post="immune pathology and mortalityJ. Immunol.20081802562257210.4049/jimmunol.180.4.256218250467 125.MinodaY.VirshupI.Leal RojasI.HaighO.WongY.MilesJ.J.WellsC.A.RadfordK.J.Human CD141(+) Dendritic"/>
  <result pre="influenza-induced pulmonary immune pathology and mortalityJ. Immunol.20081802562257210.4049/jimmunol.180.4.256218250467 125.MinodaY.VirshupI.Leal RojasI.HaighO.WongY.MilesJ.J.WellsC.A.RadfordK.J.Human CD141(+)" exact="Dendritic Cell" post="and CD1c(+) Dendritic Cell Undergo Concordant Early Genetic Programming"/>
  <result pre="and mortalityJ. Immunol.20081802562257210.4049/jimmunol.180.4.256218250467 125.MinodaY.VirshupI.Leal RojasI.HaighO.WongY.MilesJ.J.WellsC.A.RadfordK.J.Human CD141(+) Dendritic Cell and CD1c(+)" exact="Dendritic Cell" post="Undergo Concordant Early Genetic Programming after Activation in Humanized"/>
  <result pre="Activation in Humanized Mice In VivoFront. Immunol.20178141910.3389/fimmu.2017.0141929163495 126.HaoX.KimT.S.BracialeT.J.Differential response of" exact="respiratory" post="dendritic cell subsets to influenza virus infectionJ. Virol.2008824908491910.1128/JVI.02367-0718353940 127.HelftJ.ManicassamyB.GuermonprezP.HashimotoD.SilvinA.AgudoJ.BrownB.D.SchmolkeM.MillerJ.C.LeboeufM.et"/>
  <result pre="migratory CD103(+) dendritic cells control CD8 T cell immunity during" exact="acute" post="influenza infectionPLoS ONE20138e6613610.1371/journal.pone.006613623750278 129.NgS.L.TeoY.J.SetiaganiY.A.KarjalainenK.RuedlC.Type 1 Conventional CD103(+) Dendritic Cells"/>
  <result pre="efficiently transport influenza virus to the lymph node and load" exact="viral" post="antigen onto MHC class I for presentation to CD8"/>
  <result pre="Immunol.20111876011602110.4049/jimmunol.110098722043017 132.MountA.M.SmithC.M.KupresaninF.StoermerK.HeathW.R.BelzG.T.Multiple dendritic cell populations activate CD4+ T cells after" exact="viral" post="stimulationPLoS ONE20083e169110.1371/journal.pone.000169118301768 133.HildnerK.EdelsonB.T.PurthaW.E.DiamondM.MatsushitaH.KohyamaM.CalderonB.SchramlB.U.UnanueE.R.DiamondM.S.et al.Batf3 deficiency reveals a critical role"/>
  <result pre="activate CD4+ T cells after viral stimulationPLoS ONE20083e169110.1371/journal.pone.000169118301768 133.HildnerK.EdelsonB.T.PurthaW.E.DiamondM.MatsushitaH.KohyamaM.CalderonB.SchramlB.U.UnanueE.R.DiamondM.S.et al.Batf3" exact="deficiency" post="reveals a critical role for CD8alpha+ dendritic cells in"/>
  <result pre="134.YuC.I.BeckerC.MetangP.MarchesF.WangY.ToshiyukiH.BanchereauJ.MeradM.PaluckaA.K.Human CD141+ dendritic cells induce CD4+ T cells to produce" exact="type 2" post="cytokinesJ. Immunol.20141934335434310.4049/jimmunol.140115925246496 135.DudziakD.KamphorstA.O.HeidkampG.F.BuchholzV.R.TrumpfhellerC.YamazakiS.CheongC.LiuK.LeeH.W.ParkC.G.et al.Differential antigen processing by dendritic cell"/>
  <result pre="in Gut HealthImmune Netw.201919e610.4110/in.2019.19.e630838161 139.WolfA.I.BuehlerD.HensleyS.E.CavanaghL.L.WherryE.J.KastnerP.ChanS.WeningerW.Plasmacytoid dendritic cells are dispensable during" exact="primary" post="influenza virus infectionJ. Immunol.200918287187910.4049/jimmunol.182.2.87119124730 140.LuiG.ManchesO.AngelJ.MolensJ.P.ChaperotL.PlumasJ.Plasmacytoid dendritic cells capture and"/>
  <result pre="influenza virus infectionJ. Immunol.200918287187910.4049/jimmunol.182.2.87119124730 140.LuiG.ManchesO.AngelJ.MolensJ.P.ChaperotL.PlumasJ.Plasmacytoid dendritic cells capture and cross-present" exact="viral" post="antigens from influenza-virus exposed cellsPLoS ONE20094e711110.1371/journal.pone.000711119771163 141.HemannE.A.SjaastadL.E.LangloisR.A.LeggeK.L.Plasmacytoid Dendritic Cells"/>
  <result pre="from influenza-virus exposed cellsPLoS ONE20094e711110.1371/journal.pone.000711119771163 141.HemannE.A.SjaastadL.E.LangloisR.A.LeggeK.L.Plasmacytoid Dendritic Cells Require Direct" exact="Infection" post="to Sustain the Pulmonary Influenza A Virus-Specific CD8 T"/>
  <result pre="ONE20094e711110.1371/journal.pone.000711119771163 141.HemannE.A.SjaastadL.E.LangloisR.A.LeggeK.L.Plasmacytoid Dendritic Cells Require Direct Infection to Sustain the" exact="Pulmonary" post="Influenza A Virus-Specific CD8 T Cell ResponseJ. Virol.2015902830283710.1128/JVI.02546-1526719269 142.CruzJ.L.Perez-GironJ.V.LudtkeA.Gomez-MedinaS.RuibalP.IdoyagaJ.Munoz-FontelaC.Monocyte-derived"/>
  <result pre="T Cell ResponseJ. Virol.2015902830283710.1128/JVI.02546-1526719269 142.CruzJ.L.Perez-GironJ.V.LudtkeA.Gomez-MedinaS.RuibalP.IdoyagaJ.Munoz-FontelaC.Monocyte-derived dendritic cells enhance protection against" exact="secondary" post="influenza challenge by controlling the switch in CD8(+) T-cell"/>
  <result pre="controlling the switch in CD8(+) T-cell immunodominanceEur. J. Immunol.20174734535210.1002/eji.20164652327859043 143.WuH.HaistV.BaumgartnerW.SchughartK.Sustained" exact="viral" post="load and late death in Rag2-/- mice after influenza"/>
  <result pre="not of IgM or IgA isotypes can cure influenza virus" exact="pneumonia" post="in SCID miceJ. Virol.1995692075208110.1128/JVI.69.4.2075-2081.19957884853 145.BrownD.M.LeeS.Garcia-Hernandez MdeL.SwainS.L.Multifunctional CD4 cells expressing"/>
  <result pre="lethal influenza virus infectionJ. Virol.2012866792680310.1128/JVI.07172-1122491469 146.BrownD.M.DilzerA.M.MeentsD.L.SwainS.L.CD4 T Cell-Mediated Protection from" exact="Lethal" post="Influenza: Perforin and Antibody-Mediated Mechanisms Give a One-Two PunchJ."/>
  <result pre="response in lung tissueJ. Virol.1996704411441810.1128/JVI.70.7.4411-4418.19968676464 148.GrahamM.B.BracialeV.L.BracialeT.J.Influenza virus-specific CD4+ T helper" exact="type 2" post="T lymphocytes do not promote recovery from experimental virus"/>
  <result pre="with cytotoxic potential during influenza virus infectionJ. Virol.201387118841189310.1128/JVI.01461-1323986597 151.BettsR.J.PrabhuN.HoA.W.LewF.C.HutchinsonP.E.RotzschkeO.MacaryP.A.KemenyD.M.Influenza A" exact="virus infection" post="results in a robust, antigen-responsive, and widely disseminated Foxp3+"/>
  <result pre="cytotoxic potential during influenza virus infectionJ. Virol.201387118841189310.1128/JVI.01461-1323986597 151.BettsR.J.PrabhuN.HoA.W.LewF.C.HutchinsonP.E.RotzschkeO.MacaryP.A.KemenyD.M.Influenza A virus" exact="infection" post="results in a robust, antigen-responsive, and widely disseminated Foxp3+"/>
  <result pre="availabilityNat. Commun.20145349510.1038/ncomms449524633065 154.BelzG.T.XieW.AltmanJ.D.DohertyP.C.A previously unrecognized H-2D(b)-restricted peptide prominent in the" exact="primary" post="influenza A virus-specific CD8(+) T-cell response is much less"/>
  <result pre="A virus-specific CD8(+) T-cell response is much less apparent following" exact="secondary" post="challengeJ. Virol.2000743486349310.1128/JVI.74.8.3486-3493.200010729122 155.BenderB.S.CroghanT.ZhangL.SmallP.A.Jr.Transgenic mice lacking class I major histocompatibility"/>
  <result pre="lacking class I major histocompatibility complex-restricted T cells have delayed" exact="viral" post="clearance and increased mortality after influenza virus challengeJ. Exp."/>
  <result pre="infectionJ. Immunol.20081814918492510.4049/jimmunol.181.7.491818802095 158.KimC.W.YooH.J.ParkJ.H.OhJ.E.LeeH.K.Exogenous Interleukin-33 Contributes to Protective Immunity via Cytotoxic" exact="T-Cell" post="Priming against Mucosal Influenza Viral InfectionViruses20191184010.3390/v11090840 159.KrammerF.SmithG.J.D.FouchierR.A.M.PeirisM.KedzierskaK.DohertyP.C.PaleseP.ShawM.L.TreanorJ.WebsterR.G.et al.InfluenzaNat. Rev."/>
  <result pre="Interleukin-33 Contributes to Protective Immunity via Cytotoxic T-Cell Priming against" exact="Mucosal" post="Influenza Viral InfectionViruses20191184010.3390/v11090840 159.KrammerF.SmithG.J.D.FouchierR.A.M.PeirisM.KedzierskaK.DohertyP.C.PaleseP.ShawM.L.TreanorJ.WebsterR.G.et al.InfluenzaNat. Rev. Dis. Primers20184310.1038/s41572-018-0002-y29955068 160.SchmidtM.E.VargaS.M.The"/>
  <result pre="to Protective Immunity via Cytotoxic T-Cell Priming against Mucosal Influenza" exact="Viral" post="InfectionViruses20191184010.3390/v11090840 159.KrammerF.SmithG.J.D.FouchierR.A.M.PeirisM.KedzierskaK.DohertyP.C.PaleseP.ShawM.L.TreanorJ.WebsterR.G.et al.InfluenzaNat. Rev. Dis. Primers20184310.1038/s41572-018-0002-y29955068 160.SchmidtM.E.VargaS.M.The CD8 T"/>
  <result pre="al.InfluenzaNat. Rev. Dis. Primers20184310.1038/s41572-018-0002-y29955068 160.SchmidtM.E.VargaS.M.The CD8 T Cell Response to" exact="Respiratory" post="Virus InfectionsFront. Immunol.2018967810.3389/fimmu.2018.0067829686673 161.SunJ.MadanR.KarpC.L.BracialeT.J.Effector T cells control lung inflammation"/>
  <result pre="Response to Respiratory Virus InfectionsFront. Immunol.2018967810.3389/fimmu.2018.0067829686673 161.SunJ.MadanR.KarpC.L.BracialeT.J.Effector T cells control" exact="lung inflammation" post="during acute influenza virus infection by producing IL-10Nat. Med.20091527728410.1038/nm.192919234462"/>
  <result pre="Virus InfectionsFront. Immunol.2018967810.3389/fimmu.2018.0067829686673 161.SunJ.MadanR.KarpC.L.BracialeT.J.Effector T cells control lung inflammation during" exact="acute" post="influenza virus infection by producing IL-10Nat. Med.20091527728410.1038/nm.192919234462 162.GrahamM.B.BracialeT.J.Resistance to"/>
  <result pre="Immunol.2018967810.3389/fimmu.2018.0067829686673 161.SunJ.MadanR.KarpC.L.BracialeT.J.Effector T cells control lung inflammation during acute influenza" exact="virus infection" post="by producing IL-10Nat. Med.20091527728410.1038/nm.192919234462 162.GrahamM.B.BracialeT.J.Resistance to and recovery from"/>
  <result pre="161.SunJ.MadanR.KarpC.L.BracialeT.J.Effector T cells control lung inflammation during acute influenza virus" exact="infection" post="by producing IL-10Nat. Med.20091527728410.1038/nm.192919234462 162.GrahamM.B.BracialeT.J.Resistance to and recovery from"/>
  <result pre="producing IL-10Nat. Med.20091527728410.1038/nm.192919234462 162.GrahamM.B.BracialeT.J.Resistance to and recovery from lethal influenza" exact="virus infection" post="in B lymphocyte-deficient miceJ. Exp. Med.19971862063206810.1084/jem.186.12.20639396777 163.LeeB.O.Rangel-MorenoJ.Moyron-QuirozJ.E.HartsonL.MakrisM.SpragueF.LundF.E.RandallT.D.CD4 T cell-independent"/>
  <result pre="IL-10Nat. Med.20091527728410.1038/nm.192919234462 162.GrahamM.B.BracialeT.J.Resistance to and recovery from lethal influenza virus" exact="infection" post="in B lymphocyte-deficient miceJ. Exp. Med.19971862063206810.1084/jem.186.12.20639396777 163.LeeB.O.Rangel-MorenoJ.Moyron-QuirozJ.E.HartsonL.MakrisM.SpragueF.LundF.E.RandallT.D.CD4 T cell-independent"/>
  <result pre="Exp. Med.19971862063206810.1084/jem.186.12.20639396777 163.LeeB.O.Rangel-MorenoJ.Moyron-QuirozJ.E.HartsonL.MakrisM.SpragueF.LundF.E.RandallT.D.CD4 T cell-independent antibody response promotes resolution of" exact="primary" post="influenza infection and helps to prevent reinfectionJ. Immunol.20051755827583810.4049/jimmunol.175.9.582716237075 164.WaffarnE.E.BaumgarthN.Protective"/>
  <result pre="163.LeeB.O.Rangel-MorenoJ.Moyron-QuirozJ.E.HartsonL.MakrisM.SpragueF.LundF.E.RandallT.D.CD4 T cell-independent antibody response promotes resolution of primary influenza" exact="infection" post="and helps to prevent reinfectionJ. Immunol.20051755827583810.4049/jimmunol.175.9.582716237075 164.WaffarnE.E.BaumgarthN.Protective B cell"/>
  <result pre="cell responses to flu--no fluke!J. Immunol.20111863823382910.4049/jimmunol.100209021422252 165.TamuraS.KurataT.Defense mechanisms against influenza" exact="virus infection" post="in the respiratory tract mucosaJpn. J. Infect. Dis.20045723624715623947 166.HensleyS.E.DasS.R.BaileyA.L.SchmidtL.M.HickmanH.D.JayaramanA.ViswanathanK.RamanR.SasisekharanR.BenninkJ.R.et"/>
  <result pre="responses to flu--no fluke!J. Immunol.20111863823382910.4049/jimmunol.100209021422252 165.TamuraS.KurataT.Defense mechanisms against influenza virus" exact="infection" post="in the respiratory tract mucosaJpn. J. Infect. Dis.20045723624715623947 166.HensleyS.E.DasS.R.BaileyA.L.SchmidtL.M.HickmanH.D.JayaramanA.ViswanathanK.RamanR.SasisekharanR.BenninkJ.R.et"/>
  <result pre="fluke!J. Immunol.20111863823382910.4049/jimmunol.100209021422252 165.TamuraS.KurataT.Defense mechanisms against influenza virus infection in the" exact="respiratory" post="tract mucosaJpn. J. Infect. Dis.20045723624715623947 166.HensleyS.E.DasS.R.BaileyA.L.SchmidtL.M.HickmanH.D.JayaramanA.ViswanathanK.RamanR.SasisekharanR.BenninkJ.R.et al.Hemagglutinin receptor binding"/>
  <result pre="cellular cytotoxicity is associated with control of pandemic H1N1 influenza" exact="virus infection" post="of macaquesJ. Virol.2013875512552210.1128/JVI.03030-1223468501 173.ChoiY.S.BaumgarthN.Dual role for B-1a cells in"/>
  <result pre="cytotoxicity is associated with control of pandemic H1N1 influenza virus" exact="infection" post="of macaquesJ. Virol.2013875512552210.1128/JVI.03030-1223468501 173.ChoiY.S.BaumgarthN.Dual role for B-1a cells in"/>
  <result pre="against the Influenza A VirusViruses20191140510.3390/v11050405 177.GrodelandG.Baranowska-HustadM.AbadejosJ.BlaneT.R.TeijaroJ.NemazeeD.BogenB.Induction of Cross-Reactive and Protective" exact="Antibody" post="Responses After DNA Vaccination With MHCII-Targeted Stem Domain From"/>
  <result pre="virus H7N9 isolate can be masked by a mixed R/K" exact="viral" post="populationmBio2013410.1128/mBio.00396-13 186.BurnhamA.J.BaranovichT.GovorkovaE.A.Neuraminidase inhibitors for influenza B virus infection: Efficacy"/>
  <result pre="IAV genome is divided into eight segments that encode 11" exact="viral" post="proteins in total (HA, NA, M1, M2, NP, NS1,"/>
  <result pre="divided into eight segments that encode 11 viral proteins in" exact="total" post="(HA, NA, M1, M2, NP, NS1, NS2, PA, PB1,"/>
  <result pre="M2, NP, NS1, NS2, PA, PB1, PB2, and PB1-F2). The" exact="viral" post="envelope of IAV contains the transmembrane proteins HA, NA,"/>
  <result pre="HA and enters cells via endocytosis. After fusion of the" exact="viral" post="envelope and endosomal membrane, vRNPs are released into the"/>
  <result pre="the nucleus to initiate replication. RdRP is responsible for both" exact="viral" post="mRNA transcription and vRNA replication. Newly synthesized vRNPs are"/>
  <result pre="subsets in the lung and DC-mediated immune responses. After influenza" exact="virus infection," post="viral antigen-captured cDCs migrate to lymph nodes draining from"/>
  <result pre="the lung and DC-mediated immune responses. After influenza virus infection," exact="viral" post="antigen-captured cDCs migrate to lymph nodes draining from the"/>
  <result pre="cDC1s are generally characterized as cross-presenting DCs. pDCs, which produce" exact="type I" post="IFNs, play a minor role in anti-influenza virus responses,"/>
 </snippets>
</snippetsTree>
